Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple Myeloma
Clinical trial NCT02332850 · COMPLETED
Trial details
- NCT number
- NCT02332850
- Sponsor
- Thomas Martin, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-21
- Primary completion
- 2025-12-31
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.